MG
BVS icon

Michael Gelband’s Bioventus BVS Stock Holding History

Michael Gelband’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$266K Buy
+28,154
New +$269K ﹤0.01% 1386
2026
Q1 		– Sell
-44,907
Closed -$334K – 1586
2025
Q4 		$334K Buy
+44,907
New +$323K ﹤0.01% 1280
2025
Q2 		– Sell
-28,119
Closed -$257K – 1490
2025
Q1 		$257K Buy
28,119
+2,638
+10% +$26.4K ﹤0.01% 1260
2024
Q4 		$268K Sell
25,481
-13,362
-34% -$158K ﹤0.01% 1307
2024
Q3 		$464K Buy
+38,843
New +$336K ﹤0.01% 1215
2024
Q2 		– Sell
-19,498
Closed -$101K – 1549
2024
Q1 		$101K Sell
19,498
-15,372
-44% -$75.1K ﹤0.01% 1413
2023
Q4 		$184K Buy
+34,870
New +$138K ﹤0.01% 1292

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Michael Gelband's BVS Position: Q2 2026 in Review

Michael Gelband opened a new position in Bioventus (BVS) in Q2 2026: 28,154 shares worth $266K. The stake represents ﹤0.01% of the portfolio and ranks #1386 among its holdings. This is a return to the name: Michael Gelband previously reported a position in BVS as recently as Q4 2025.

Michael Gelband first reported a position in BVS in Q4 2023 and has held it in 7 quarters since. The position peaked at $464K in Q3 2024. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Michael Gelband held 28,154 shares of Bioventus worth $266K as of Q2 2026.
  • Bioventus was a new Michael Gelband position in Q2 2026.
  • Bioventus made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1386 holding.
  • Michael Gelband first reported a position in Bioventus in Q4 2023 and has held it in 7 quarters since.
  • Michael Gelband's Bioventus position peaked at $464K in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.